Drug intelligence / Profile preview

Qu Tan Hua Yu granules

Development stage
Unknown
Lead developer
Liaoning University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Qu Tan Hua Yu granules is a Traditional Chinese Medicine (TCM) formulation developed by Liaoning University of Traditional Chinese Medicine. It is primarily indicated for the treatment of coronary heart disease (CHD) and stable angina pectoris, specifically targeting patients with the TCM syndrome of 'Spleen deficiency generating phlegm' and 'phlegm-stasis' (Tan Yu). The formulation is designed to resolve phlegm (Qu Tan) and transform blood stasis (Hua Yu), which are considered central pathological factors in the development of myocardial ischemia and atherosclerosis in TCM theory. In clinical research, it has been evaluated in Phase 3 trials as part of an integrative TCM regimen, often combined with Yi Qi Jian Pi granules, to improve clinical symptoms, reduce the frequency of angina attacks, and enhance overall cardiac function.

Other names
Qu Tan Hua Yu Ke LiQutan Huayu granules
02

Targets

NF-κBNOX4 (NADPH oxidase 4)

Beyond the preview

Go deeper on Qu Tan Hua Yu granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qu Tan Hua Yu granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call